摘要
目的:研究国产医用抛射剂HFC-134a的急性毒性,为进一步扩大其在医疗上的应用提供可靠的实验安全数据。方3法:将60只昆明小鼠分成5组,每组12只,雌雄各半,分设剂量为0、100、500、1000、5000mg/m,连续吸入HFC-134a气体染毒4h,后常规饲料喂养,期间每天观察小鼠行为学改变,7d后处死小鼠,比较染毒前后小鼠体质量变化,并行大体病理形态学检查,观察肝、肾、胰腺等脏器的变化。结果:与阴性对照组相比,染毒组小鼠体质量,行为及肝、肾、胰腺等脏器未发现异常3改变。最高给药剂量(5000mg/m吸入4h)组,无动物死亡,平均体质量增至(26.3±5.8)g,无致炎、致敏和中毒反应。结论:在本实验条件下,医用抛射剂HFC-134a未发现明显的急性毒副反应,常规用药剂量安全。
OBJECTIVE: To investigate the toxicity of medical propellant HFC-134a, in order to provide scientific basis for promoting the application of HFC-134a on medicine. METHODS: 60 Kunming mice were divided into 5 groups, 12 mice each group, male and female in half: 0, 100, 500, 1 000, 5 000 mg/m3. The acute toxicity was conducted with mice exposed for 4 hours, to observe the change of animal behavior. Then all mice were sacrificed after 7 days. The change of mice weight and the pathomorphology of liver, kidney and pancreas were observed. RESULTS: Compared with negative control group, the weight of liver, kidney and pancreas did not show any abnormality. No animal died under the maximum dose. The average weight increase was (26.3 ± 5.8) g, and there was no irritation or toxicity found through respiratory tract contamination. CONCLUSION: There were no obvious acute toxicity and side effects on the experimental subjects. HFC-134a could be used as a medicine safely. [KEY WORDS1 HFC-134a; propellant; LC50; acute toxicity
出处
《癌变.畸变.突变》
CAS
CSCD
2013年第1期64-66,共3页
Carcinogenesis,Teratogenesis & Mutagenesis